Giannoni, A
4 Efforts to extend the life of native GLP-1 led to the development of human GLP-1 analogs liraglutide, albiglutide, dulaglutide, and semaglutide
is supported by an Australian National Health and Medical Research Council Senior Principal Research Fellowship (GNT1059660) and has received grants from the US NIH, the Australian Cooperative Research Centre, the Simons Autism Foundation, the Cancer Council of Victoria, the Stanley Medical Research Foundation, the Medical Benefits Foundation, Beyond Blue, Rotary Health and the Geelong Medical Research Foundation
GLP-1 therapy for pre-diabetes: This approach is a powerful, preventative measure, making it easier to reverse the trend toward diabetes
Side effects like nausea tend to appear 24 hours after injection and gradually subside over 24 hours, occurring at similar rates whether you inject in the morning or evening
Compounding pharmacies still require you to have a legitimate prescription before buying medications
